Felicitas Kühne

Time-to-event versus ten-year-absolute-risk in cardiovascular risk prevention – does it make a difference? Results from the Optimizing-Risk-Communication (OptRisk) randomized-controlled trial

Charles Christian Adarkwah, Nikita Jegan, Monika Heinzel‐Gutenbrunner et al. · BMC Medical Informatics and Decision Making · 2016 · 33 citations · Full text

Cost-effectiveness of use of 20-valent pneumococcal conjugate vaccine among adults in Germany

Felicitas Kühne, Katharina Achtert, Franziska Püschner et al. · Expert Review of Vaccines · 2023 · 23 citations · Full text

A Microsimulation of the Cost-effectiveness of Maraviroc for Antiretroviral Treatment-Experienced HIV-Infected Individuals

Felicitas Kühne, J Chancellor, Patrick Mollon et al. · HIV Clinical Trials · 2010 · 17 citations

Lessons Learned from a Cross-Model Validation between a Discrete Event Simulation Model and a Cohort State-Transition Model for Personalized Breast Cancer Treatment

Beate Jahn, Ursula Rochau, Christina Kurzthaler et al. · Medical Decision Making · 2015 · 14 citations

Cost of transfusion-dependent myelodysplastic syndrome (MDS) from a German payer’s perspective

Felicitas Kühne, Thomas Mittendorf, Ulrich Germing et al. · Annals of Hematology · 2010 · 14 citations · Full text

Healthcare Value, Health Economics, Transfusion Medicine +12